Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects

• Status: Completed
• Trial end date: 2005-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the amount of metabolites of ATL-962 in the blood and to investigate the effect of ATL-962 on the amount of fat that is excreted in the faeces in subjects who are obese

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Alizyme
• Treatments: Cetilistat

Criteria

Inclusion Criteria:

• Obese, otherwise-healthy subjects

• Body mass index 30-45kg/m2

Exclusion Criteria:

• Women who are pregnant or breast feeding

• Any drug treatment within 2 weeks of commencement of dosing in this study